Publications by authors named "Laura Michaelis"

Claim this Profile
4
40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies.
Kristen Corrao, Adrian Umpierrez, Angela Treml, Aniko Szabo, Laura Michaelis

Haematologica· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based frontline treatment.
Sameem Abedin, Geoffrey L Uy, Laura C Michaelis

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.
Sameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C Michaelis, Karen-Sue Carlson

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Laura Michaelis

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Laura C Michaelis

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An extensive database analysis demonstrates significant increase in platelet quantity in unselected hospitalized patients following treatment with oseltamivir.
Chandrasekar Muthiah, Qinghua Lian, Samantha Benz, Aniko Szabo, Karin Hoffmeister, Laura C Michaelis

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
Karen-Sue Carlson, Ashley Cunningham, Maximilian Stahl, Eric Winer, Laura C Michaelis

Acta Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.
Scott R Solomon, Bayard L Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C Michaelis

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I diagnose and treat thrombocytopenia in geriatric patients.
Patrick Foy, Kenneth D Friedman, Laura C Michaelis

Blood· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy.
Skyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, Laura C Michaelis, Karen Carlson

Leuk Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Rory M Shallis, Naval Daver, Jessica K Altman, Rami S Komrokji, Daniel A Pollyea, Laura C Michaelis

Lancet Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.
Tamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, Brandon McMahon, Sanjay R Mohan, Laura C Michaelis

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Credible Sources of Health Information in Social Media: Phase 2-Considerations for Non-Accredited Nonprofit Organizations, For-Profit Entities, and Individual Sources.
Helen Burstin, Susan Curry, Megan L Ranney, Vineet Arora, Brian Boxer Wachler, Laura Michaelis

NAM Perspect· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.
Megan Othus, Ian Thomas, Xu Wang, Cono Ariti, Priyanka Mehta, Laura C Michaelis

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia.
Sameem M Abedin, Talha Badar, Katelyn Gauger, Laura C Michaelis, Lyndsey Runaas

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies.
Meera Mohan, Sneha Nagavally, Nirav N Shah N, Laura Michaelis, Saurabh Chhabra

Clin Lymphoma Myeloma Leuk· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Clinical Study to Investigate the Hypomethylating Properties of Freeze-dried Black Raspberries in Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasm.
Athena Dong, Xiaoqing Pan, Chien-Wei Lin, Yi-Wen Huang, Hayden Krause, Laura Michaelis

J Cancer Prev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.
Kristen Corrao, Siam Rezwan, Ehab Atallah, Laura C Michaelis, Lyndsey Runaas

Leuk Res Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive nodular histiocytosis with dramatic response to cobimetinib.
Philip C Berce, Leah Cardwell, Amber N Essenmacher, Laura C Michaelis, Karolyn A Wanat

JAAD Case Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia.
Daniel A Pollyea, John Barrett, Courtney D DiNardo, Laura C Michaelis, Gail J Roboz

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there an optimal adjunct therapy to traditional cytotoxic induction?
Laura C Michaelis

Best Pract Res Clin Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avapritinib in the Treatment of Systemic Mastocytosis: an Update.
Samantha Below, Laura C Michaelis

Curr Hematol Malig Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The next wave: immunizing the immunosuppressed.
Laura C Michaelis

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
Muhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, Laura C Michaelis, Karen-Sue B Carlson

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis